Get the Stockscreener App
7.23
0.69%
-0.05
After Hours:
7.23
Bioventus Inc stock is traded at $7.23, with a volume of 309.83K.
It is down -0.69% in the last 24 hours and down -1.09% over the past month.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
See More
Previous Close:
$7.28
Open:
$7.28
24h Volume:
309.83K
Relative Volume:
0.70
Market Cap:
$483.63M
Revenue:
$555.06M
Net Income/Loss:
$-39.48M
P/E Ratio:
-12.05
EPS:
-0.6
Net Cash Flow:
$29.05M
1W Performance:
+0.56%
1M Performance:
-1.09%
6M Performance:
-28.20%
1Y Performance:
-33.73%
1-Day Range:
$7.07
$7.28
1-Week Range:
$6.98
$7.41
52-Week Range:
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
Name
Bioventus Inc
Sector
Industry
Phone
(919) 474-6700
Address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
7.23 | 468.25M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-17-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-07-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-09-23 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-22-22 | Downgrade | Craig Hallum | Buy → Hold |
| Nov-09-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-09-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Mar-15-22 | Initiated | Craig Hallum | Buy |
| Nov-15-21 | Resumed | Morgan Stanley | Overweight |
| Nov-10-21 | Resumed | JP Morgan | Overweight |
| Jul-01-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-08-21 | Initiated | Canaccord Genuity | Buy |
| Mar-08-21 | Initiated | Goldman | Buy |
| Mar-08-21 | Initiated | JP Morgan | Overweight |
| Mar-08-21 | Initiated | Morgan Stanley | Overweight |
View All
Bioventus Inc Stock (BVS) Latest News
Cubist Systematic Strategies LLC Acquires 116,418 Shares of Bioventus Inc. $BVS - MarketBeat
Peripheral nerve stimulator Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes, DelveInsight | B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwav - Barchart.com
Investors Hope for Bounce in Bioventus Inc. After SelloffCPI Data & Stepwise Trade Signal Guides - beatles.ru
Will Bioventus Inc. Reverse From Oversold ConditionsGDP Growth & Free Risk Controlled Daily Trade Plans - beatles.ru
Published on: 2025-09-08 13:50:02 - beatles.ru
Will Bioventus Inc. benefit from seasonalityJuly 2025 Weekly Recap & AI Enhanced Execution Alerts - beatles.ru
Is now the right time to enter Bioventus Inc.2025 Fundamental Recap & Daily Chart Pattern Signal Reports - beatles.ru
Bioventus enters into a new $400M credit agreement, lowering interest expenses - MSN
What recovery options are there for Bioventus Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser
Bioventus Inc. $BVS Shares Bought by Nantahala Capital Management LLC - MarketBeat
Should I buy Bioventus Inc. stock nowMarket Trend Summary & Capital Efficient Trade Techniques - خودرو بانک
Will Bioventus Inc. benefit from sector rotationRate Hike & Weekly High Conviction Trade Ideas - خودرو بانک
Applying sector rotation models to Bioventus Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Key metrics from Bioventus Inc.’s quarterly dataJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
How to monitor Bioventus Inc. with trend dashboards2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
Detecting support and resistance levels for Bioventus Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
Quant Strategy Flags Bioventus Inc. for EntryQuarterly Market Review & Safe Capital Allocation Plans - beatles.ru
Applying big data sentiment scoring on Bioventus Inc.Trend Reversal & Low Volatility Stock Recommendations - Newser
Is it time to cut losses on Bioventus Inc.2025 Short Interest & Consistent Profit Alerts - Newser
Invesco Ltd. Purchases 248,932 Shares of Bioventus Inc. $BVS - MarketBeat
Published on: 2025-09-04 00:52:16 - Newser
How to use Fibonacci retracement on Bioventus Inc.July 2025 Trends & Short-Term Swing Trade Alerts - Newser
Bioventus Inc. stock trendline breakdownJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Bioventus Inc. Sees Spike in Bullish Option Flow2025 Year in Review & Daily Chart Pattern Signals - beatles.ru
Will Bioventus Inc. bounce back from current support2025 Trading Recap & High Accuracy Trade Signal Alerts - Newser
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Global Active Healing Leader Bioventus to Present at Morgan Stanley's 23rd Healthcare Conference - Stock Titan
Published on: 2025-09-03 04:15:11 - Newser
Visualizing Bioventus Inc. stock with heatmapsPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - Newser
Real time scanner hits for Bioventus Inc. explainedJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
Bioventus Inc. $BVS Shares Bought by Vanguard Group Inc. - MarketBeat
Bioventus Inc. recovery potential after sell offJuly 2025 Action & Weekly High Potential Alerts - Newser
Bioventus Inc. stock outlook for YEARProduct Launch & Daily Entry Point Alerts - Newser
Returns Recap: Can Bioventus Inc. maintain sales growthMarket Activity Summary & Advanced Technical Signal Analysis - خودرو بانک
What makes Bioventus Inc. stock price move sharplyJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Candlestick signals on Bioventus Inc. stock todayQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
What indicators show strength in Bioventus Inc.July 2025 News Drivers & Entry and Exit Point Strategies - Newser
Can Bioventus Inc. deliver alphaCEO Change & Smart Money Movement Tracker - خودرو بانک
Bioventus Inc. stock volume spike explained2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
What’s next for Bioventus Inc. stock priceNew Guidance & AI Driven Stock Movement Reports - Newser
Published on: 2025-09-01 03:23:38 - Newser
Gains Recap: Will Bioventus Inc. outperform the market in YEARDip Buying & Smart Money Movement Tracker - 한국정경신문
Key resistance and support levels for Bioventus Inc.Index Update & Safe Swing Trade Setup Alerts - Newser
How to forecast Bioventus Inc. trends using time seriesQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
Technical analysis overview for Bioventus Inc. stockRisk Management & Reliable Entry Point Trade Alerts - Newser
Bioventus Inc Stock (BVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):